Vietnamese Journal of Neurology

Article detail

Article detail description

Home
Articles Issue: Vietnamese Journal of Neurology No.39 Tổng quan

Gut Dysbiosis: Its Relation to Cardiovascular Risk Factors

Published: November 20, 2023
Views: 3

Abstract

Microorganisms are highly diverse and abundantly present in the natural environment. They typically enter the human body about 8 hours after birth and then reside on the surface of the skin and mucous membranes, such as those of the digestive, respiratory, and genital tracts. Each area of the body has differences in the composition and quantity of these microorganisms. Among these, the gastrointestinal tract hosts the richest microbiota, accounting for up to 90%. From there, they gradually increase in number and diversify in species within just 1-2 years.

The gut contains 100 trillion microbes, weighing approximately 1-2 kg. Bacteria make up 97%, archaea 0.1-0.2%, viruses 0.1%, and fungi 0.03-0.1%, with beneficial bacteria comprising 85% and harmful bacteria 15%. The number of microbes is ten times greater than the number of living cells in an adult human body, and their genetic material totals over 3 million genes, which is 150 times the number of human genes.

References

1.
Smiljanec K. et al (2019). Sodium, hypertension and the gut: does the gut microbiota go salty. Am. J. physiol Heart Circ Physiol 317.
2.
Liu Y et al (2020). Gut microbiome Fermentation Determines the efficacy of exercise for diabetes prevention. Cell Metabolism, 31; 77-91.
3.
Rittiphairoj Th. et al (2021). Probiotics contribute to glycemic control in patients with type 2 diabetes mellitus: A systematic Review and Meta-analysis. Adv Nutr 2021; 12:722-734.
4.
Xiong Y. et al (2021). The Role of Gut microbiota in hypertension pathogenesis and the of antihypertensive drugs. Curent Hypertension reports (2021) 23:40.
5.
Zhang X. et al (2022). Diet Gut Microbiota interactions in cardiovascular disease. Computational and structural Biotechnology J.20; 1528-1540.
6.
Bielka W. et al (2022): The role of the Gut Microbiota in Pathogenesis of Diabetes. Int. J. Mol. Sci. 2022, 2, 480: 1-2.
7.
Naseri K. et al (2022). Beneficial effects of probiotics and synbiotics supplementation on some cardiovascular risk factors among individuals with prediabetes and type 2 diabetes mellitus: A grade - assessed systematic review, meta-analysis, meta-regression on randomized clinical trials. Pharma.Research Vol 182, 106288.
8.
Naseri K. et al (2022). Probiotics and synbiotics supplementation improve glycemic control parameters in subjects with prediabetes and type 2 diabetes mellitus: A grade - assessed systematic review, meta-analysis, meta-regression on randomized clinical trials. Pharma.Research Vol 184, 106399.
9.
Kant R. et al (2022). Gut micriota interactions with anti-diabetics medications and pathogenesis of type 2 diabetes mellitus 12 (4):246-257.
10.
Int.J. Mol. Sci 2023, 24, 1377.
11.
Zarezadeh M. (2023). Effect of probiotic supplementation on blood pressure: An umbrella meta-analysis of randomized controlled trials. Nutrition, Metabolism & Cardiovascular diseases (2023) 33, 275-286.
12.
Zhao et al (2023). Long term use of probiotic for the management of office and ambulatory blood pressure: A Systematic review and meta-analysis of randomized, controlled trials. Food Science & Nutrition.
13.
Flaig B. et al (2023). Treatment of dyslipidemia through targeted therapy of Gut Microbiota. Nutrients, 15, 228, 1-30.

Authors

  • Hoang Khanh

Files

Article Views3
Document Views0
Downloads0
Section Articles
Category Tổng quan